SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta‐analysis
出版年份 2021 全文链接
标题
SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta‐analysis
作者
关键词
-
出版物
ESC Heart Failure
Volume 8, Issue 3, Pages 2210-2219
出版商
Wiley
发表日期
2021-03-22
DOI
10.1002/ehf2.13313
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease
- (2020) Kazuomi Kario et al. PROGRESS IN CARDIOVASCULAR DISEASES
- SGLT2i: beyond the glucose-lowering effect
- (2020) Lihua Ni et al. Cardiovascular Diabetology
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians
- (2019) Awadhesh Kumar Singh et al. Diabetes Therapy
- Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis
- (2019) Hillel Sternlicht et al. CURRENT HYPERTENSION REPORTS
- Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
- (2019) Eri T. Kato et al. CIRCULATION
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial
- (2019) David A. Morrow et al. CIRCULATION
- Direct effects of empagliflozin on extracellular matrix remodeling in human cardiac myofibroblasts: Novel translational clues to EMPA-REG OUTCOME
- (2019) Sean Kang et al. CANADIAN JOURNAL OF CARDIOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction
- (2018) R. De Vecchis et al. HERZ
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
- (2016) Nicolas M. Berbenetz et al. BMC Cardiovascular Disorders
- Optimal Use of Beta-Blockers for Congestive Heart Failure
- (2016) Hae-Young Lee et al. CIRCULATION JOURNAL
- Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
- (2016) Ele Ferrannini et al. DIABETES
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID2): an evidence-based mnemonic for the treatment of systolic heart failure
- (2016) N. Chia et al. INTERNAL MEDICINE JOURNAL
- Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure
- (2016) Gregg C. Fonarow et al. JAMA Cardiology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
- (2012) K. Stenlöf et al. DIABETES OBESITY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search